GET THE APP

Journal of Leukemia

Journal of Leukemia
Open Access

ISSN: 2329-6917

+44 1300 500008

Journal of Leukemia : Citations & Metrics Report

Articles published in Journal of Leukemia have been cited by esteemed scholars and scientists all around the world. Journal of Leukemia has got h-index 11, which means every article in Journal of Leukemia has got 11 average citations.

Following are the list of articles that have cited the articles published in Journal of Leukemia.

  2021 2020 2019 2018 2017 2016

Year wise published articles

62 23 11 8 22 23

Year wise citations received

54 59 64 98 109 74
Journal total citations count 618
Journal impact factor 2.11
Journal 5 years impact factor 3.71
Journal cite score 3.91
Journal h-index 11
Journal h-index since 2018 8
Important citations (462)

Diabetes, but not pre-diabetes, is associated with shorter time to second-line therapy and worse outcomes in patients with multiple myeloma

Ríos-tamayo r, pérez mj, rodríguez ds, chang-chan yl. epidemiology of multiple myeloma. inmultiple myeloma 2018 nov 5. intechopen.

Shukla p. umbilical cord preservation-a review. biochem mol biol lett. 2017;3(1):109.

Levy i, vadasz z, polliack a, tadmor t. the frequency and prognostic value of neutrophilia in chronic lymphocytic leukemia. anticancer research. 2018 aug 1;38(8):4731-4.

raja ramesh gv. cancer metastasis and its suppressor genes. biochem mol biol lett. 2017;3(2):116.

alwash mm. evaluation of cd69 as a prognostic factor and its relation with other prognosticatos in a sample of iraqi patients with chronic lymphocytic leukemia. mustansiriya medical journal. 2018 jun 29;14(2):6-.

Kirtava t, vatsadze t, azrmaiparashili e, ghirdaladze d. the prognostic significance of combaind expression of zap-70 and cd38 in chronic lymphocytic leukemia. georgian medical news. 2017 jun(267):12-6.

Climans sa, cecchini mj, hsia cc, bondy lc, shkrum mj, roth ke, fraser ja. chronic myelomonocytic leukemia mimicking invasive fungal rhinosinusitis. canadian journal of neurological sciences. 2018 sep;45(5):596-8.

Umbilical cord preservation- a review

Clinical case of transitory anomalomy myelopoesis in a newborn

Clinical observation of transient leukemia in a child with down syndrome

miachon aa, de martino lee ml, guerra-junior g, spinola-castro am. are survivors of childhood acute lymphoblastic leukemia at increased risk for low bone mass?. journal of leukemia. 2014 aug 26.

mcgill cm, brown tj, fisher ln, gustafson sj, dunlap kl, beck aj, toran pt, claxton df, barth bm. combinatorial efficacy of quercitin and nanoliposomal ceramide for acute myeloid leukemia. international journal of biopharmaceutical sciences. 2018;1(1).

Бигильдеев АЕ. УСТРОЙСТВО И РЕГУЛЯЦИЯ ОТДЕЛА СТВОЛОВЫХ МЕЗЕНХИМНЫХ КЛЕТОК. Москва. 2017.

bansal p. research and reviews: journal of microbiology and biotechnology.

kirova ym, horn s, chen j. évolution des techniques d'irradiation pour la prise en charge de la maladie de hodgkin: histoire et avenir. cancer/radiotherapie. 2017 aug 1;21(5):400-3.

kirova ym, chen j. évolution de techniques d’irradiation dans le cadre de la maladie de hodgkin: il est temps de proposer des techniques modernes à tous nos patients. innovations & thérapeutiques en oncologie. 2017 jan 1;3(1):39-40.

starke a, bowden j, lynn r, hall k, hudson k, rato a, aldridge e, robb d, steele p, brady j, mikhaeel ng. comparison of butterfly volumetric modulated arc therapy to full arc with or without deep inspiration breath hold for the treatment of mediastinal lymphoma. radiotherapy and oncology. 2018 dec 1;129(3):449-55.

meyer e, goudjil f, tamburini j, dendale r, kirova y. proton beam therapy for the management of mediastinal hodgkin lymphoma in a young female patient. cancer radiotherapie: journal de la societe francaise de radiotherapie oncologique. 2018 may;22(3):296.

horn s, fournier-bidoz n, pernin v, peurien d, vaillant m, dendale r, fourquet a, kirova ym. comparison of passive-beam proton therapy, helical tomotherapy and 3d conformal radiation therapy in hodgkin's lymphoma female patients receiving involved-field or involved site radiation therapy. cancer/radiothérapie. 2016 apr 1;20(2):98-103.

Top